Comprehensive Ascertainment of Bleeding in Patients Prescribed Different Combinations of Dual Antiplatelet Therapy (DAPT) and Triple Therapy (TT) in the UK: Study Protocol for Three Population-Based Cohort Studies Emulating ‘Target Trials’ (The ADAPTT Study)

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-029388
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy)Clinical Perspective

Circulation
Cardiovascular MedicinePhysiologyCardiology
2017English

Individualized Antiplatelet Therapy After Drug-Eluting Stent Deployment: Implication of Clinical Trials of Different Durations of Dual Antiplatelet Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Dual Antiplatelet Therapy After Stenting in All-Comers, ACS Patients and in High Bleeding Risk

English

Efficacy and Safety of 12 Versus 48 Months of Dual Antiplatelet Therapy After Implantation of a Drug-Eluting Stent: The OPTImal DUAL Antiplatelet Therapy (OPTIDUAL) Trial: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2013English

Efficacy and Safety of Triple Therapy Versus Dual Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A Meta-Analysis

PLoS ONE
Multidisciplinary
2018English

Dual Antiplatelet Therapy in Ischemic Stroke

Turk Beyin Damar Hastaliklar Dergisi
NeurologyCardiovascular MedicineCardiology
2019English

Cardiovascular and Bleeding Risk of Non-Cardiac Surgery in Patients on Antiplatelet Therapy

Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

The Risk of Pancreatitis With Sitagliptin Therapy in Older Adults: A Population-Based Cohort Study

CMAJ Open
2015English

The Underutilisation of Dual Antiplatelet Therapy in Acute Coronary Syndrome

International Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy